| Title | Nuclear receptor signaling |
| Abbreviation | Nucl. recept. signal. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Medicine (miscellaneous) (Q2) |
| h-index | 34 |
| Overall Rank/Ranking | 7797 |
| SCImago Journal Rank (SJR) | 0.630 |
| Impact Score | 0.00 |
| Publisher | Nuclear Receptor Signaling Atlas |
| Country | United States |
| ISSN | 15507629 |
| Best Quartile | Q2 |
| Coverage History | 2007-2016, 2018 |
Nuclear receptor signaling is a journal covering the technologies/fields/categories related to Medicine (miscellaneous) (Q2). It is published by Nuclear Receptor Signaling Atlas. The overall rank of Nuclear receptor signaling is 7797. According to SCImago Journal Rank (SJR), this journal is ranked 0.630. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 34. The best quartile for this journal is Q2.
The ISSN of Nuclear receptor signaling journal is 15507629. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Nuclear receptor signaling is cited by a total of 10 articles during the last 3 years (Preceding 2021).
The Impact IF 2021 of Nuclear receptor signaling is 0.00, which is computed in 2022 as per its definition. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2021 of Nuclear receptor signaling is 0.00. If the same downward trend persists, Impact IF may fall in 2022 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2021 | 0.00 |
| 2020 | 3.67 |
| 2019 | 0.00 |
| 2018 | 2.50 |
| 2017 | 3.88 |
| 2016 | 3.67 |
| 2015 | 2.29 |
| 2014 | 7.25 |
Nuclear receptor signaling has an h-index of 34. It means 34 articles of this journal have more than 34 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Nuclear receptor signaling is 15507629. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Nuclear receptor signaling is 7797. According to SCImago Journal Rank (SJR), this journal is ranked 0.630. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2021 | 0.630 |
| 2020 | 0.434 |
| 2019 | 0.513 |
| 2018 | 1.409 |
| 2017 | 1.483 |
| 2016 | 1.654 |
| 2015 | 1.399 |
| 2014 | 2.442 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2021 | 7797 |
| 2020 | 11357 |
| 2019 | 9569 |
| 2018 | 2513 |
| 2017 | 2350 |
| 2016 | 2000 |
| 2015 | 2685 |
| 2014 | 964 |
Nuclear receptor signaling is published by Nuclear Receptor Signaling Atlas. It's publishing house is located in United States. Coverage history of this journal is as following: 2007-2016, 2018. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Nuclear receptor signaling is Nucl. recept. signal.. This abbreviation ('Nucl. recept. signal.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Medicine (miscellaneous) (Q2), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Nuclear receptor signaling latest impact IF is 0.00. It's evaluated in the year 2021. The highest and the lowest impact IF or impact score of this journal are 7.25 (2014) and 0.00 (2021), respectively, in the last 8 years. Moreover, its average IS is 2.91 in the previous 8 years.
The Nuclear receptor signaling has an SJR (SCImago Journal Rank) of 0.630, according to the latest data. It is computed in the year 2022. In the past 8 years, this journal has recorded a range of SJR, with the highest being 2.442 in 2014 and the lowest being 0.434 in 2020. Furthermore, the average SJR of the Nuclear receptor signaling over the previous 8-year period stands at 2.91.
The latest h-index of the Nuclear receptor signaling is 34.
The Nuclear receptor signaling is published by the Nuclear Receptor Signaling Atlas, with its country of publication being the United States.
The Nuclear receptor signaling is currently ranked 7797 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 8 years, this journal has experienced varying rankings, reaching its highest position of 964 in 2014 and its lowest position of 11357 in 2020.
The standard ISO4 abbreviation for the Nuclear receptor signaling is Nucl. recept. signal..
Nuclear receptor signaling is classified as a journal that the Nuclear Receptor Signaling Atlas publishes.
The Nuclear receptor signaling encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Nuclear receptor signaling is assigned the following International Standard Serial Numbers (ISSN): 15507629.
The best quartile for the Nuclear receptor signaling is Q2 (2021).
The Nuclear receptor signaling coverage history can be summarized as follows: 2007-2016, 2018.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Journal of Applied Business Research | journal | 23890 | 29 | 0.28 | |
| Journal of Supply Chain Management | journal | 378 | Wiley-Blackwell | 104 | 12.58 |
| Journal of Education and Work | journal | 9268 | Brill Academic Publishers | 43 | 1.93 |
| Modern Language Journal | journal | 918 | Wiley-Blackwell | 103 | 3.89 |
| Syntax | journal | 3422 | Wiley-Blackwell Publishing Ltd | 29 | 0.93 |
| Proceedings of the Technical Association of the Graphic Arts, TAGA | conference and proceedings | 30903 | Technical Association of the Graphic | 8 | 0.00 |
| Built Environment | journal | 12797 | Alexandrine Press | 43 | 1.15 |
| Journal of Immigrant and Refugee Studies | journal | 9246 | Routledge | 32 | 1.46 |
| Proteomics - Clinical Applications | journal | 9140 | Wiley-VCH Verlag | 59 | 2.02 |
| Archiv fur Geflugelkunde | journal | 28770 | Verlag Eugen Ulmer | 30 | 0.00 |
| Year | Impact Score (IS) |
|---|---|
| 2022/2023 | Coming Soon |
| 2021 | 0.00 |
| 2020 | 3.67 |
| 2019 | 0.00 |
| 2018 | 2.50 |
| 2017 | 3.88 |
| 2016 | 3.67 |
| 2015 | 2.29 |
| 2014 | 7.25 |
